Capital Management Associates Edwards Lifesciences Corp Transaction History

Capital Management Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $437,304 - $584,820	7,600 Added 200.0%	11,400 $788,000
Q3 2018 Nov 06, 2018	BUY	$45.7 - $58.03 $43,186 - $54,838	945 Added 33.1%	3,800 $662,000
Q2 2018 Aug 02, 2018	BUY	$42.45 - $51.3 $121,194 - $146,461	2,855 New	2,855 $416,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Capital Management Associates , based on Form 13F filings with the SEC.

Stay updated on Capital Management Associates with notifications on news.